
Vapcar 400mg Tablet DT
Marketer
Neovap Biopharmaceuticals Pvt. Ltd.
Salt Composition
Sevelamer (400mg)
Overview Vapcar 400mg Tablet DT
Fosrenol 400mg delayed-release tablets manage elevated blood phosphate levels in dialysis patients with advanced kidney disease. This medication reduces intestinal phosphate absorption, thereby lowering serum phosphate concentrations. Administer Fosrenol 400mg with food, following your physician's prescribed dosage and regimen. Consistent, daily dosing at the same time maximizes therapeutic effects. Potential side effects include nausea, vomiting, abdominal discomfort, constipation, and diarrhea. Reduced blood levels of calcium and vitamins A, D, E, K, and folic acid are also possible; supplemental therapies should be guided by your doctor.
Primary Ingredients of Vapcar 400mg Tablet DT
No information provided. Please provide the text you wish me to rephrase.
Uses of Vapcar 400mg Tablet DT
Elevated serum phosphate concentration
Major Benefits of Vapcar 400mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve the Vapcar 400mg Tablet DT in water before consumption. It should be administered with food.
Common Side effects of Vapcar 400mg Tablet DT:
- Abdominal pain
- Diarrhea
- Flatulence
- Vomiting
- Constipation
- Nausea
How to use Vapcar 400mg Tablet DT:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Dissolve one tablet in water prior to consumption. Ingest Vapcar 400mg Tablet DT with a meal.
How Vapcar 400mg Tablet DT works:
Vapcar 400mg Delayed-Release Tablets reduce blood phosphate levels by hindering intestinal phosphate uptake.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vapcar 400mg Tablet DT is of unknown safety. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Vapcar 400mg Delayed-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available evidence, the use of Vapcar 400mg Delayed-Release Tablets while breastfeeding appears to pose minimal risk to the infant. Studies in humans suggest negligible harm to the nursing child.
DrivingCONSULT YOUR DOCTOR
Vapcar 400mg Tablet DT's effect on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Vapcar 400mg extended-release tablets are considered safe for use in individuals with impaired renal function. No dosage modification is necessary for Vapcar 400mg extended-release tablets in this population. Nevertheless, routine monitoring of serum calcium concentrations is prudent.
LiverSAFE IF PRESCRIBED
Vapcar 400mg extended-release tablets appear to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Vapcar 400mg Tablet DT :
Omit any missed Vapcar 400mg Tablet DT dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Vapcar 400mg Tablet DT
| Label | Value |
|---|---|
| Chemical Category | Oxirane |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
